Product apis-gpcr-g-protein

Home > products > apis> gpcr-g-protein

Catalog	name	Description	price
R-R-2841	GLP-1R modulator L7-028 CAS No.2648317-95-5	GLP-1R modulator L7-028/CAS No.2648317-95-5 is an allosteric modulator enhancing GLP-1 binding to GLP-1R via a transmembrane site (EC50 11.01 ± 2.73 μM).	price>
R-R-2842	GLP-1R modulator C16 CAS No.875005-43-9	GLP-1R modulator C16/CAS No.875005-43-9 is an allosteric modulator enhancing GLP-1 binding to GLP-1R via a transmembrane site (EC50 8.43 ± 3.82 μM).	price>
R-R-2843	GLP-1 receptor agonist 2 CAS No.2230197-64-3	GLP-1 receptor agonist 2/CAS No.2230197-64-3 is a glucagon-like peptide-1 receptor (GLP-1R) agonist.	price>
R-R-2844	LSN3318839 CAS No.2764704-18-7	LSN3318839/CAS No.2764704-18-7 is an orally efficacious positive allosteric modulator of the glucagon-like peptide-1 receptor (GLP-1R).	price>
R-R-2845	TT-OAD2 CAS No.2382719-60-8	TT-OAD2/CAS No.2382719-60-8 is a non-peptide glucagon-like peptide-1 (GLP-1) receptor agonist with an EC50 of 5 nM. TT-OAD2 has the potential for diabetes treatment.	price>
R-R-2846	GLP-1R modulator C5 CAS No.421578-93-0	GLP-1R modulator C5/CAS No.421578-93-0 is an allosteric modulator enhancing GLP-1 binding to GLP-1R via a transmembrane site (EC50 1.59 ± 0.53 μM).	price>
R-R-2847	GRA Ex-25 CAS No.307983-31-9	GRA Ex-25/CAS No.307983-31-9 is an inhibitor of glucagon receptor, with IC50 of 56 and 55 nM for rat and human glucagon receptors, respectively.	price>
R-R-2848	Ecnoglutide CAS No.2459531-73-6	Ecnoglutide (XW003)/CAS No.2459531-73-6 is a long-acting, cAMP-biased glucagon-like peptide 1 (GLP-1) receptor agonist. Ecnoglutide can be used for research of T2DM and obesity.	price>
R-R-2849	Volagidemab CAS No.1233956-13-2	Volagidemab/CAS No.1233956-13-2 is an antagonistic glucagon receptor (GCGR) monoclonal antibody (mAb). Volagidemab can be used in the research of type 1 diabetes (T1D).	price>
R-R-2850	Survodutide TFA	Survodutide (BI 456906) TFA is a potent, selective glucagon receptor/GLP-1 receptor (GCGR/GLP-1R) dual agonist with EC50s of 0.52 nM and 0.33 nM in CHO-K1 cells, respectively. Survodutide TFA, a 29-amino-acid peptide, is a potent acylated peptide containing a C18 fatty acid. Survodutide TFA has robust anti-obesity efficacy achieved by increasing energy expenditure and decreasing food intake.	price>

...

163